These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 33401881)

  • 1. The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes.
    Lee YJ; Lee YA; Kim JH; Chung HR; Gu MJ; Kim JY; Shin CH
    Ann Pediatr Endocrinol Metab; 2020 Dec; 25(4):248-255. PubMed ID: 33401881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up.
    Coronel-Restrepo N; Blanco VM; Palacio A; Ramírez-Rincón A; Arbeláez S; Duque V; Pino JJ; Carvajal J; Bedoya J; Cuesta DP; Botero JF
    Endocrinol Diabetes Nutr (Engl Ed); 2020 Dec; ():. PubMed ID: 33358488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?
    Scheuing N; Badenhoop K; Borkenstein M; Konrad K; Lilienthal E; Laubner K; Naeke A; Rami-Merhar B; Thon A; Wiemann D; Holl RW;
    Pediatr Diabetes; 2015 Feb; 16(1):10-5. PubMed ID: 24984902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic control of type 1 diabetes in youth with autism spectrum disorder: A multicenter Diabetes-Patienten-Verlaufsdokumentation analysis based on 61 749 patients up to 20 years of age.
    Lemay JF; Lanzinger S; Pacaud D; Plener PL; Fürst-Burger A; Biester T; Hilgard D; Lilienthal E; Galler A; Berger G; Holl RW;
    Pediatr Diabetes; 2018 Aug; 19(5):930-936. PubMed ID: 29582531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
    Viñals C; Quirós C; Giménez M; Conget I
    Diabetes Ther; 2019 Jun; 10(3):929-936. PubMed ID: 30900146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years.
    Wong JC; Dolan LM; Yang TT; Hood KK
    Pediatr Diabetes; 2015 Dec; 16(8):592-9. PubMed ID: 25387433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data.
    Šimonienė D; Platūkiene A; Prakapienė E; Radzevičienė L; Veličkiene D
    Diabetes Ther; 2020 Jan; 11(1):161-174. PubMed ID: 31792784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of insulin pump therapy on key parameters of diabetes management and diabetes related emotional distress in the first 12 months.
    Oldham V; Mumford B; Lee D; Jones J; Das G
    Diabetes Res Clin Pract; 2020 Aug; 166():108281. PubMed ID: 32628980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
    Colino Alcol E; López Capapé M; Alvarez Gómez MA; Alonso Blanco M; Martín Frías M; Barrio Castellanos R
    An Pediatr (Barc); 2006 Jan; 64(1):21-7. PubMed ID: 16539912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden.
    Jendle J; Smith-Palmer J; Delbaere A; de Portu S; Papo N; Valentine W; Roze S
    Diabetes Ther; 2017 Oct; 8(5):1015-1030. PubMed ID: 28871565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
    Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
    Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of a comprehensive diabetes program for glycemic control and adherence, and the selection of candidates for sensor-augmented insulin pump therapy.
    Botero JF; Vásquez LM; Blanco VM; Cuesta DP; Ramírez-Rincón A; Bedoya J; Palacio A
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Mar; ():. PubMed ID: 33812905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.